全文获取类型
收费全文 | 126900篇 |
免费 | 10693篇 |
国内免费 | 767篇 |
专业分类
耳鼻咽喉 | 557篇 |
儿科学 | 3669篇 |
妇产科学 | 4287篇 |
基础医学 | 10027篇 |
口腔科学 | 2705篇 |
临床医学 | 13032篇 |
内科学 | 24003篇 |
皮肤病学 | 1484篇 |
神经病学 | 9988篇 |
特种医学 | 3970篇 |
外国民族医学 | 1篇 |
外科学 | 12296篇 |
综合类 | 3263篇 |
现状与发展 | 12篇 |
一般理论 | 43篇 |
预防医学 | 31188篇 |
眼科学 | 1439篇 |
药学 | 7207篇 |
31篇 | |
中国医学 | 237篇 |
肿瘤学 | 8921篇 |
出版年
2024年 | 171篇 |
2023年 | 6916篇 |
2022年 | 10178篇 |
2021年 | 10380篇 |
2020年 | 11179篇 |
2019年 | 7786篇 |
2018年 | 8309篇 |
2017年 | 8891篇 |
2016年 | 8465篇 |
2015年 | 7310篇 |
2014年 | 12995篇 |
2013年 | 11113篇 |
2012年 | 4660篇 |
2011年 | 2790篇 |
2010年 | 6320篇 |
2009年 | 4916篇 |
2008年 | 1633篇 |
2007年 | 1909篇 |
2006年 | 1344篇 |
2005年 | 997篇 |
2004年 | 588篇 |
2003年 | 702篇 |
2002年 | 808篇 |
2001年 | 789篇 |
2000年 | 560篇 |
1999年 | 853篇 |
1998年 | 795篇 |
1997年 | 606篇 |
1996年 | 688篇 |
1995年 | 600篇 |
1994年 | 422篇 |
1993年 | 327篇 |
1992年 | 171篇 |
1991年 | 186篇 |
1990年 | 186篇 |
1989年 | 159篇 |
1988年 | 257篇 |
1987年 | 252篇 |
1986年 | 274篇 |
1985年 | 119篇 |
1984年 | 107篇 |
1983年 | 106篇 |
1982年 | 74篇 |
1981年 | 64篇 |
1980年 | 46篇 |
1979年 | 43篇 |
1978年 | 44篇 |
1977年 | 33篇 |
1975年 | 31篇 |
1974年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Oxidative stress and inflammation are two possible mechanisms related to nephrotoxicity caused by environmental pollutants. Ellagic acid, a powerful antioxidant phytochemical, may have great relevance in mitigating pollutant-induced nephrotoxicity and preventing the progression of kidney disease. This review discusses the latest findings on the protective effects of ellagic acid, its metabolic derivatives, the urolithins, against kidney toxicity caused by heavy metals, pesticides, mycotoxins, and organic air pollutants. We describe the chelating, antioxidant, anti-inflammatory, antifibrotic, antiautophagic, and antiapoptotic properties of ellagic acid to attenuate nephrotoxicity. Furthermore, we present the molecular targets and signaling pathways that are regulated by these antioxidants, and suggest some others that should be explored. Nevertheless, the number of reports is still limited to establish the efficacy of ellagic acid against kidney damage induced by environmental pollutants. Therefore, additional preclinical studies on this topic are required, as well as the development of well-designed clinical trials. 相似文献
82.
Vilar-Compte Mireya Gaitán-Rossi Pablo Félix-Beltrán Lucía Bustamante Arturo V. 《Journal of immigrant and minority health / Center for Minority Public Health》2022,24(1):65-77
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to... 相似文献
83.
《Nursing outlook》2022,70(4):566-569
With the adoption of value-based payments which tie reimbursement to patient outcomes and costs, days when nursing is viewed primarily as a cost to hospitals will soon be over. Already the backbone of high-quality care delivery and patient outcomes, nurses are becoming key drivers of health care organizations' financial outcomes, too. The first three articles published in this 6-part series on value-informed nursing practice—practice that considers both the outcomes and the cost of producing the outcomes—described what value-informed nursing practice means, its economic, policy, and ethical impetuses, and how value-informed nursing practice helps improve environmental sustainability of health systems. Here, in Part 4, we focus on the importance of nursing innovation in implementing value-informed nursing practice. We begin by discussing how innovation is connected to value and then examine the false dichotomy, perceived by many, between innovation and evidence-based care. Following this, we examine how health care organizations and systems can support nursing innovation, before concluding with recommendations for nursing educators. 相似文献
84.
85.
86.
87.
《The American journal of medicine》2022,135(7):879-888.e3
ObjectivesClinical trials have shown a beneficial effect from biological disease-modifying antirheumatic drugs (bDMARDs) on hand or axial bone loss in patients with rheumatoid arthritis; however, it is unclear if this translates to a reduced fracture risk. We investigated the effect of bDMARDs on osteoporotic fracture risk compared to no biological treatment in rheumatoid arthritis.MethodsA cohort of patients with rheumatoid arthritis aged 18+ from DANBIO was linked to population-based health registries in Denmark (2006-2016). Adopting a prevalent new-user design, we matched bDMARD users to bDMARD-naïve patients using time-conditional propensity scores. The risk of incident osteoporotic fractures (including hip, vertebrae, humerus, and forearm) was estimated among the matched patients by Cox proportional hazards models.ResultsOut of 24,678 patients with rheumatoid arthritis, 4265 bDMARD users were matched to the same number of bDMARD-naïve patients (mean age 56.2 years, 74% female). During follow-up, 229 osteoporotic fractures occurred among bDMARD users and 205 fractures among bDMARD-naïve patients (incidence rates 12.1 and 13.0 per 1000 person-years, respectively). The use of bDMARDs was not associated with a reduced risk of osteoporotic fractures among patients with rheumatoid arthritis (hazard ratio 0.97, 95% confidence interval 0.78-1.20), compared with no biological treatment. The risk estimates were similar for all osteoporotic fracture sites.ConclusionWe found no independent beneficial effect from using bDMARDs on reducing the risk of osteoporotic fractures in patients with rheumatoid arthritis. 相似文献
88.
89.
《The Canadian journal of cardiology》2022,38(10):1570-1579
South Asians (SAs) experience a higher prevalence and earlier onset of coronary artery disease and have worse outcomes compared with White Caucasians (WCs) following invasive revascularisation procedures, a mainstay of coronary artery disease (CAD) management. We sought to review the differences in the CAD pattern and risk factors between SA and WC patients and to discuss their potential impact on the development of coronary disease, acute coronary syndrome, and revascularisation outcomes. SAs have a more diffuse pattern with multivessel involvement compared with WCs. However, less is known about other morphologic characteristics, such as calcification of atherosclerotic plaque and coronary diameter in SA populations. Despite a similar coronary calcification burden, higher noncalcified plaque composition, elevated thrombosis, and inflammatory markers likely contribute to the disease pattern. Although the current evidence on the role of coronary vessel size remains inconsistent, smaller diameters in SAs could play a potential role in the higher disease prevalence. This is especially important given the impact of coronary artery diameter on revascularisation outcomes. In conclusion, SAs have a unique CAD risk profile composed of traditional and novel risk factors. Our findings highlight the need for additional awareness of health professionals of this specific risk profile and potential therapeutic targets, as well as the need for further research in this vulnerable population. 相似文献
90.